Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.20.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of reportable business segment information
Reportable business segment information is as follows (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2020 2019
Net sales:    
Asia $ 30,958    $ 33,596   
Europe 20,627    15,597   
North America 38,757    36,523   
Latin America and Other 5,584    5,556   
Total net sales 95,926    91,272   
Contribution margin (1):    
Asia 14,527    15,725   
Europe 6,831    4,941   
North America 14,419    13,793   
Latin America and Other 2,450    2,371   
Total contribution margin 38,227    36,830   
Selling, general and administrative expenses (2) 31,065    33,852   
Operating income 7,162    2,978   
Other loss, net (2,410)   (48)  
Income before provision for income taxes $ 4,752    $ 2,930   
_________________________________________

(1)   Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2)  Service fees in China totaled $1.9 million and $2.2 million for the three-month periods ended March 31, 2020 and 2019, respectively. These service fees are included in selling, general and administrative expenses.
Schedule of consolidated net sales revenue by geographical locations
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three-month periods ended March 31, 2020 and 2019, as follows (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2020 2019
Net sales:    
United States $ 35,839    $ 33,961   
South Korea 16,389    18,528   
Other 43,698    38,783   
  $ 95,926    $ 91,272   
Schedule of revenue generated by each of the Company's product lines
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
 
  Three Months Ended
March 31,
  2020 2019
Asia    
General health $ 9,046    $ 8,084   
Immune 201    158   
Cardiovascular 9,339    11,833   
Digestive 6,156    4,775   
Personal care 3,005    4,267   
Weight management 3,211    4,479   
  30,958    33,596   
Europe    
General health $ 7,961    $ 5,748   
Immune 2,444    1,273   
Cardiovascular 2,897    2,851   
Digestive 4,931    3,631   
Personal care 1,751    1,499   
Weight management 643    595   
  20,627    15,597   
North America    
General health $ 15,464    $ 15,748   
Immune 7,798    4,218   
Cardiovascular 4,167    5,076   
Digestive 8,241    8,721   
Personal care 1,929    1,348   
Weight management 1,158    1,412   
  38,757    36,523   
Latin America and Other    
General health $ 1,614    $ 1,612   
Immune 809    608   
Cardiovascular 378    339   
Digestive 2,362    2,536   
Personal care 252    257   
Weight management 169    204   
  5,584    5,556   
  $ 95,926    $ 91,272   
Schedule of consolidated property, plant and equipment by geographical locations
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
 
  March 31,
2020		 December 31,
2019
Property, plant and equipment:    
United States $ 53,450    $ 54,470   
Other 4,638    5,042   
Total property, plant and equipment, net $ 58,088    $ 59,512   
Schedule of assets per segment
Total assets per segment is set forth below (dollar amounts in thousands):

March 31,
2020		 December 31,
2019
Assets:    
Asia $ 65,199    $ 65,959   
Europe 15,171    15,187   
North America 127,178    124,337   
Latin America and Other 7,894    7,585   
Total assets $ 215,442    $ 213,068